RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 2000; 83(06): 963-964
DOI: 10.1055/s-0037-1613951
DOI: 10.1055/s-0037-1613951
Letters to the Editor
In the Presence of other Inherited or Acquired High-risk Situations, the FV Cambridge Mutation May Be an Additional Thrombophilic Risk Factor, through Its Effect on APC Sensitivity
Weitere Informationen
Publikationsverlauf
Received
20. Dezember 1999
Accepted after resubmission
29. Januar 2000
Publikationsdatum:
14. Dezember 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/200006/lookinside/thumbnails/10-1055-s-0037-1613951-1.jpg)
-
References
- 1 Dahlbäck B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J Clin Invest 1994; 94: 923-7.
- 2 Rodeghiero F, Tosetto A. Activated protein C resistance and Factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med 1999; 130: 643-50.
- 3 Bernardi F, Faioni EM, Castoldi E, Lunghi B, Castaman G, Sacchi E, Mannucci PM. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 1997; 90: 1552-7.
- 4 Williamson D, Brown K, Luddington R, Baglin C, Baglin T. Factor V Cambridge. A new mutation associated with resistance to activated protein C. Blood 1998; 91: 1140-4.
- 5 Franco RF, Maffei FH, Lourenco D, Morelli V, Thomazini IA, Piccinato CE, Tavella MH, Zago MA. Factor V Arg306→Thr (Factor V Cambridge) and Factor V Arg->306 Gly mutations in venous thrombotic disease. Br J Haematol 1998; 103: 888-90.
- 6 Ames PRJ, Catello T, Iannaccone L, Brillante M, Cimino R, Brancaccio V. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies. A crucial role for acquired free protein S deficiency. Thromb Haemost 1996; 76: 190-4.
- 7 Koeleman BPC, Reitsma PH, Allart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 84: 1031-5.
- 8 Margaglione M, D’Andrea G, Grandone E, Brancaccio V, Amoriello A, Di Minno G. Compound heterozygosity (554-589 del, C515-T transition) in the platelet glycoprotein Ib( gene in a patient with a severe bleeding tendency. Thromb Haemost 1999; 81: 486-92.